Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest Interventional cardiology Stories

2014-02-21 23:04:31

The current issue of the Journal of Endovascular Therapy offers results of a prospective study seeking to establish the rate of 1-year restenosis in diabetic patients with femoropopliteal in-stent restenosis who underwent treatment with drug-eluting balloon angioplasty. Lawrence, Kansas (PRWEB) February 21, 2014 Despite good immediate results, in up to 40 percent of patients, obstructed arteries in the leg treated with a stent will again become blocked. This in-stent restenosis is...

2014-02-21 16:23:00

NEW YORK, Feb. 21, 2014 /PRNewswire/ -- Pomerantz LLP has filed a class action lawsuit against Thoratec Corporation ("Thoratec" or the "Company")(NASDAQ: THOR) and certain of its officers. The class action, filed in United States District Court, Northern District of California, and docketed under 14-cv-00360, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Thoratec securities between April 29, 2010 and November 27, 2013 both dates...

2014-02-19 08:34:19

PLEASANTON, Calif., and SINGAPORE, Feb. 19, 2014 /PRNewswire/ -- TriReme Medical LLC, a subsidiary of Singapore based QT Vascular Ltd., announced today that it has signed a broad distribution agreement with Cordis Corporation for the exclusive distribution of its unique ChocolateĀ® PTA Balloon Angioplasty Catheter, with an option for additional TriReme portfolio products. This agreement will expand TriReme's commercial footprint and allow the company to focus on its promising...

2014-02-14 12:24:18

DUBLIN, February 14, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/9pskcb/2013_australia) have announced the addition of the "Australia Procedure Volumes Database" [http://www.researchandmarkets.com/research/9pskcb/2013_australia ] directory to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This in-depth procedure volumes database quantifies current and forecast (2010-2017) procedure volumes...

2014-02-13 12:27:49

LONDON, Feb. 13, 2014 PRNewswire/ -- Reportbuyer.com just published a new market research report:China Interventional Cardiovascular Device Industry Report, 2013-2015 With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People's Republic of China, in 2012 cardiovascular disease deaths in China reached 3.5 million. The fast growing number of heart patients...

2014-02-13 12:26:58

Aortic Stent Grafts Will Continue To Generate the Majority of Revenues Due To Strong Acceptance in the Thoracic Indication, According to Decision Research Group BURLINGTON, Mass., Feb. 13, 2014 /PRNewswire/ -- Decision Resources Group finds that the Chinese peripheral vascular (PV) device market will grow strongly through 2022 as patients in China increasingly seek treatment for PV disease. Historically, awareness of the disease among patients and physicians was low, resulting in a...

2014-02-04 16:28:02

FRAMINGHAM, Mass., Feb. 4, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2014 Leerink Global Healthcare Conference at 8:55 a.m. EST on Thursday, February 13, 2014. The conference is being held February 12-13 at the Waldorf Astoria in New York...

2014-01-31 12:25:45

PLEASANTON, Calif., Jan. 31, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Leerink Global Healthcare Conference on Wednesday, February 12. Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the company, beginning at 3:05 p.m., Eastern Standard Time (12:05 p.m., Pacific Standard...

2014-01-28 20:22:25

DUBLIN, Ireland, January 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/fvxjv3/cardiovascular) has announced the addition of a new report "Global Cardiovascular Drug Delivery Market" [http://www.researchandmarkets.com/research/fvxjv3/cardiovascular ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Drug delivery to the cardiovascular system is different from delivery to other systems because...

2014-01-27 16:23:02

Funding will support exploration of 'final frontier' in angioplasty KANSAS CITY, Mo., Jan. 27, 2014 /PRNewswire-USNewswire/ -- Saint Luke's Mid America Heart Institute has been awarded a $3.4 million, three-year grant from Boston Scientific to investigate and better define the success, safety, health benefits, and cost-effectiveness of novel methods to open challenging blocked coronary arteries previously thought untreatable through minimally invasive techniques. One in six...


Latest Interventional cardiology Reference Libraries

Coronary Angiography
2013-07-29 11:05:01

A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...

More Articles (1 articles) »